Getinge AB (publ)の最新の1株当たり利益は$4.44で、$3.65の予想を打ちつける。
Getinge AB (publ) GNGBYの前四半期の収益はどうでしたか?
Getinge AB (publ)の前四半期の収益は$4.44です。
Getinge AB (publ)の収益見積もりはいくらですか?
6人のウォール街のアナリストによると、Getinge AB (publ)の収益見積もりは$8.4Bから$7.42Bの範囲です。
Getinge AB (publ)の収益品質スコアはどれくらいですか?
Getinge AB (publ)の収益品質スコアは/です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Getinge AB (publ)はいつ収益を報告しますか?
Getinge AB (publ)の次の収益報告は2026-04-27に予定されています
Getinge AB (publ)の予想収益はいくらですか?
ウォール街のアナリストによると、Getinge AB (publ)の予想収益は$10.37Bです。
Getinge AB (publ)は収益予想を上回りましたか?
Getinge AB (publ)の最近の収益は$10.18Bで、予想を打ち勝たない。
主要データ
前終値
$20.4
始値
$20.17
当日レンジ
$20.17 - $20.3
52週レンジ
$17.7 - $24.67
取引高
345
平均取引高
4.8K
配当利回り
--
1株当たり利益(TTM)
0.90
時価総額
$5.1B
Getinge ABとは何ですか?
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.